country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-184925

Copy Link Print Information

GPR43 agonist 1

GPR43 agonist 1 is a selective, orally active GPR43 agonist. GPR43 agonist 1 downregulates the activity of NF-κB. GPR43 agonist 1 can be used in studies of acute colitis.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Formel: C₁₉H₂₂FN₅O₃S
Molecular Weight:419.47

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

GPR43 agonist 1 Chemical Structure

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

GPR43 agonist 1 is a selective, orally active GPR43 agonist. GPR43 agonist 1 downregulates the activity of NF-κB. GPR43 agonist 1 can be used in studies of acute colitis^[1].

IC₅₀ & Target

^[1]

GPR43

Alle Free Fatty Acid Receptor Isoform-spezifische Produkte anzeigen :

Alle NF-κB Isoform-spezifische Produkte anzeigen :

In Vitro

OthersInnate ImmunityCytokines & Chemokines

Others

GPR43 agonist 1 (Compound 187) selectively inhibits cAMP production in HEK293-hGPR43 cells, with an EC₅₀ value of 16 nM^[1].
GPR43 agonist 1 is a potent positive allosteric agonist that induces Ca²⁺influx in HEK293-hGPR43 cells, with enhanced potency in the presence of acetic acid^[1].
GPR43 agonist 1 (treated for 25 min, incubated for 1 h) acts as a partial positive allosteric agonist, which induces the GPR43-β-arrestin 2 interaction in HEK293-hGPR43 cells, with enhanced activity in the presence of acetate^[1].

Innate Immunity

Cytokines & Chemokines

GPR43 agonist 1 (pretreated for 20 min and co-incubated with 10 ng/mL TNF-α for 6 h) potently inhibits TNF-α-induced NF-κB activity in HEK293-hGPR43 cells, with an EC₅₀ of 19 nM^[1].
GPR43 agonist 1 reverses TNF-α-induced IκBα degradation in HEK293-hGPR43 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Innate Immunity

GPR43 agonist 1 (30 mg/kg; p.o.; daily; 8 days) reduces colon myeloperoxidase staining but does not significantly improve clinical activity metrics or colon length in a mouse model of DSS-induced acute colitis^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

C57BL/6 (female, 6 weeks old post-acclimation)^[1]
Dosage:

30 mg/kg
Administration:

p.o.; daily; 8 days
Result:

Reduced myeloperoxidase (MPO) staining in colon tissue compared to vehicle-treated DSS-induced colitis mice.
Showed no significant change in colon length relative to vehicle-treated mice.
Reported no significant reductions in body weight loss score, rectal bleeding score, stool consistency score, or daily activity index relative to vehicle-treated mice.

Related Protocols :

Chemical Information

Molecular Weight 419.47
Formel C₁₉H₂₂FN₅O₃S
SMILES

NC1=C(S(=O)(C2=CC=CC=C2F)=O)C3=NC(C)=NC(N4C[C@@H](C)O[C@@H](C)C4)=C3N1
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Park BO, et al. Novel GPR43 Agonists Exert an Anti-Inflammatory Effect in a Colitis Model. Biomolecules & therapeutics. 2022 Jan 01;30(1):48-54. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

GPR43 agonist 1

Alle Free Fatty Acid Receptor Isoform-spezifische Produkte anzeigen

Alle NF-κB Isoform-spezifische Produkte anzeigen